64th Annual Meeting of the Japanese Society of Neurology

Session information

Print

Oral Session

[O-26] Oral Session 26

Fri. Jun 2, 2023 9:45 AM - 11:15 AM Room4 (幕張メッセ国際会議場 3F 301)

Chair:Yamano Yoshihisa (Department of Neurology, St. Marianna University School of Medicine, Japan)

[O-26-1] Prion Disease Diagnosis criteria. Comparison among the Committee and Other International Consortia

Tadashi Tsukamoto1,4, Reiko Saika1, Masaki Takao2,4, Hidehiro Mizusawa3,4, Prion Disease Surveillance Committee4 (1.Deparment of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Japan, 2.Department of Internal Medicine, National Center Hospital, National Center of Neurology and Psychiatry, Japan, 3.National Center of Neurology and Psychiatry, Japan, 4.Prion Disease Surveillance Committee, Japan)

[O-26-2] Tickborne Encephalitis in patients with acute encephalitis or meningitis of unknown etiology

Masayuki Ohira1, Kentaro Yoshii2, Ai Takano3, Yasuhiro Aso4, Hideto Nakajima5, Hidehiro Mizusawa6, Yasuhiro Kobayashi7, Lisa R. Harper8, Juanita Edwards8, Cody Bender8, Andreas Pilz8, Frederick J. Angulo8, Koji Wada7, Wilhelm Erber8, Harish Madhava8, Jennifer C. Moisi8, Luis Jodar8, Masaki Takao1 (1.Department of Clinical Laboratory, National Center of Neurology and Psychiatry (NCNP), Japan, 2.National Research Center for the Control and Prevention of Infectious Diseases, Nagasaki University, Japan, 3.Laboratory of Veterinary Epidemiology, Yamaguchi University, Japan, 4.Department of Neurology, Oita Prefectural Hospital, Japan, 5.Department of Neurology, Nihon University Itabashi Hospital, Japan, 6.National Center of Neurology and Psychiatry (NCNP), Japan, 7.Vaccine Medical Affairs, Pfizer Japan Inc., Japan, 8.Medical Development and Scientific/Clinical Affairs, Pfizer Vaccines., USA)